Clinical Trial Update: Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of Erlotinib with radiation therapy, with or without Cisplatin, in patients with mouth or throat squamous cell carcinoma (lip/oral cavity and orop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lip and Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Drugs mentioned

• CISPLATIN (cisplatin)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx | Phase 1 | Status: COMPLETED